Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases [PDF]
Yiran Liu +7 more
openalex +1 more source
Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis [PDF]
, 2020 Anna Kakehashi +8 more
openalex +1 more source
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
American Journal of Gastroenterology, 1999 E. Brunt +4 more
semanticscholar +1 more source
MedicinaIntroduction: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) stems from disrupted lipid metabolism in the liver, often linked to obesity, type 2 diabetes, and dyslipidemia.
Melchor Alpízar Salazar +8 more
doaj +1 more source
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis [PDF]
, 2021 Matt Docherty +10 more
openalex +1 more source
Frontiers in PharmacologyBackground & AimsEfruxifermin is a potential treatment for non-alcoholic steatohepatitis (NASH, now termed metabolic dysfunction-associated steatohepatitis, MASH).
Shuzhai Li +6 more
doaj +1 more source
Vascular adhesion protein 1 in nonalcoholic steatohepatitis: A novel biomarker?
, 2015 Natalie J. Török
openalex +1 more source
Diagnostik der Metabolischen Dysfunktion-assoziierten Steatohepatitis (MASH)
Monitor VersorgungsforschungDer 2. Teil der Übersichtsarbeit zur Diagnostik und Versorgung von Patienten mit Metabolisch assoziierter Steatohepatitis (MASH) thematisiert die Herausforderungen und Empfehlungen unter Berücksichtigung der aktuellen S2k-Leitlinien.
Hans-Holger Bleß +1 more
doaj +1 more source
NGM282: a step forward in the nonalcoholic steatohepatitis treatment landscape?
, 2018 Luca Valenti, Valério Nobili
openalex +2 more sources